Supply and Support of Complete Antibody Quantification Testing Systems
- NHS Blood and Transplant
Procurement identifier (OCID): ocds-h6vhtk-04fb3e
Description
Anti-D and Anti-c Antibody Quantification
NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients' by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.
Notices
UK6: Contract award notice
- Notice identifier
- 2026/S 000-014787
- Published
- 18 February 2026, 1:45pm
UK4: Tender notice
- Notice identifier
- 2025/S 000-065592
- Published
- 15 October 2025, 1:38pm
UK3: Planned procurement notice
- Notice identifier
- 2025/S 000-031206
- Published
- 10 June 2025, 11:41am
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-012222
- Published
- 1 April 2025, 12:31pm